Search research articles
Contact Us
Filters
Showing results (101-110 of 386) with videos related to
Page
of 39
Sort By:
Cancer
|
September 5, 2002
Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors)
Jeffrey D Seidman, Robert J Kurman
Otolaryngologic Clinics of North America
|
September 10, 2022
Natural Alternatives and the Common Cold and Influenza
Varun S Patel, Michael D Seidman
Gynecologic Oncology
|
May 5, 2007
Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma
Jeffrey D Seidman, Brant G Wang
Human Pathology
|
June 3, 2000
Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators
J D Seidman, R J Kurman
Human Pathology
|
December 9, 2000
Ovarian serous borderline tumors: the citadel defended
R J Kurman, J D Seidman
Seminars in Oncology
|
December 1, 1991
The evolving role of chemotherapy for muscle infiltrating bladder cancer
A D Seidman, H I Scher
Molecular Diagnosis & Therapy
|
December 15, 2007
Use of the Oncotype DX 21-gene assay to guide adjuvant decision making in early-stage breast cancer
Alison K Conlin, Andrew D Seidman
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
July 1, 1996
Pathologic findings from the Maryland Women's Health Study: practice patterns in the diagnosis of adenomyosis
J D Seidman, K H Kjerulff
The American Journal of Surgical Pathology
|
November 1, 1996
Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases
J D Seidman, R J Kurman
Otolaryngologic Clinics of North America
|
June 1, 1996
Update on tinnitus
M D Seidman, G P Jacobson
Page
of 39
Search research articles
Search
Showing results (101-110 of 386) with videos related to
Sort By:
Page
of 39
Cancer
|
September 5, 2002
Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors)
Jeffrey D Seidman, Robert J Kurman
Otolaryngologic Clinics of North America
|
September 10, 2022
Natural Alternatives and the Common Cold and Influenza
Varun S Patel, Michael D Seidman
Gynecologic Oncology
|
May 5, 2007
Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma
Jeffrey D Seidman, Brant G Wang
Human Pathology
|
June 3, 2000
Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators
J D Seidman, R J Kurman
Human Pathology
|
December 9, 2000
Ovarian serous borderline tumors: the citadel defended
R J Kurman, J D Seidman
Seminars in Oncology
|
December 1, 1991
The evolving role of chemotherapy for muscle infiltrating bladder cancer
A D Seidman, H I Scher
Molecular Diagnosis & Therapy
|
December 15, 2007
Use of the Oncotype DX 21-gene assay to guide adjuvant decision making in early-stage breast cancer
Alison K Conlin, Andrew D Seidman
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
July 1, 1996
Pathologic findings from the Maryland Women's Health Study: practice patterns in the diagnosis of adenomyosis
J D Seidman, K H Kjerulff
The American Journal of Surgical Pathology
|
November 1, 1996
Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases
J D Seidman, R J Kurman
Otolaryngologic Clinics of North America
|
June 1, 1996
Update on tinnitus
M D Seidman, G P Jacobson
Page
of 39